HT PARP in vivo Pharmacodynamic Assay II

Trevigen announces a validated assay, with higher sensitivity and pre-coated antibody plates to measure the effectiveness of PARP inhibitors in cell and tissue lysates for anticancer drug screening.

View post: 
HT PARP in vivo Pharmacodynamic Assay II

Tags: antibody-plates, drug-screening-, sensitivity

Related posts:

1. Optimization of MALDI tissue imaging and correlation with immunohistochemistry in rat kidney sections
2. Rockefeller virologists and MIT tissue engineers receive $5.8 million NIH grant to study hepatitis

Related posts brought to you by Yet Another Related Posts Plugin.

• Previous Entry: Great America with Hugh Downs to Produce a Series on Agriculture and the Need for a Healthy Planet
• Next Entry: Broadening Biology